Biotech industry will engage public to ease fear of CRISPR gene editing

Print Friendly, PDF & Email

A new gene-editing technology known as CRISPR could soon be used to alter the crops producing the food we eat — making tomatoes sweeter, for example, or vegetables more resistant to disease.

Larry Gilbertson, a longtime scientist with Monsanto, believes some of the controversy surrounding GMOs stemmed from the giant agriculture company’s lack of direct engagement with the public. Monsanto — now known as Bayer Crop Science after Bayer bought Monsanto for $63 billion this year — plans to do better with products made with CRISPR technology ….

Gilbertson was in Chicago …. at the Foodscape conference on emerging food trends. The following interview has been edited for length and clarity.
Q: Consumers who don’t like GMOs might not like gene editing either. How is Bayer planning to address their concerns?

A: First, we want to be part of the conversation …. We’re very proud of our GMO technology and we continue to support that. But we are engaging more with the public …. As a scientist, I wish I could just explain how it works and everyone would just be OK with it. But we know it’s more than just understanding. Food is emotional and I understand that …. The coolest science in the world doesn’t matter if the world isn’t ready for it.”

Related article:  Rare brain disorder—Angelman syndrome—could be treated with gene therapy in the womb
Outbreak Featured
Infographics: Key charts illustrate split between vaccinated and unvaccinated America

Infographics: Key charts illustrate split between vaccinated and unvaccinated America

Three in 10 American adults remain unvaccinated, according to the latest survey from the KFF. But they’re not a monolith ...
Are GMOs and pesticides threatening bees?

Are GMOs and pesticides threatening bees?

First introduced in 1995, neonicotinoids ...
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.